jackpot casino slot
MMA legend Chris Weidman asked to be paid show money after Eryk Anders pulled out, but the UFC declined | Sporting News
Meta to build new USD10B AI data centre
Want the Helix Midnight Luxe but don't have the budget? 5 Black Friday mattress deals to shop instead
Lignosulfonate Concrete Admixtures Market Grows with Increased Focus on Sustainable ConstructionNEW ORLEANS — Brandon Ingram scored 29 points in his return from a five-game absence, Herb Jones capped off his first game back from a shoulder injury by blocking Devin Booker's last-second shot, and the New Orleans Pelicans snapped a nine-game losing streak with a 126-124 victory over the Phoenix Suns on Thursday night. CJ McCollum scored 25 points, but missed a free throw with 3 seconds left, allowing the Suns a final shot for the win or tie. When Booker, who had 28 points, received an inbound pass at the 3-point line, he rose for a shot and had the ball swatted away by Jones, who hadn't played in 18 games. Jones had one of this four steals with 2:02 left and made a left corner 3 about 13 seconds later to give New Orleans a 121-117 lead. He finished with 12 points. Trey Murphy scored 19 points, Dejounte Murray scored 17 and rookie center Yves Missi had 12 rebounds for the Pelicans, Bradley Beal scored 24 points for Phoenix. Takeaways Suns: Playing without star forward Kevin Durant (left ankle sprain) and center Jusuf Nurkic (right thigh bruise), Phoenix still nearly won. Pelicans: With five of the top six player in their rotation on the court for the first time since late October, the Pelicans looked far more competitive than they have. Phoenix Suns guard Devin Booker (1) moves the ball around New Orleans Pelicans guard CJ McCollum in the first half of an NBA basketball game in New Orleans, Thursday, Dec. 5, 2024. Credit: AP/Gerald Herbert Key moment McCollum hit a driving floater high off the glass to put the Pelicans in front with 35 seconds left and then assisted on Murphy alley-oop dunk that made it 125-121 with 15 seconds left. Key stat The Pelicans made seven of nine 3-point attempts in the third quarter, when they turned a 65-54 deficit into a 99-93 lead. Up next The Suns visit Miami on Saturday. The Pelicans host Oklahoma City on Saturday.
MELBOURNE, Australia and ZURICH , Dec. 6, 2024 /PRNewswire/ — Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns to support the standardisation of its research services platforms and enable deeper, reproducible proteome profiling. Following extensive consultation with the Biognosys team, IonOpticks has developed a custom chromatography column, which is tailored to Biognosys’ needs and is available exclusively for use in their TrueDiscovery ® , TrueSignature ® , and TrueTarget ® contract research services. Consistent with IonOpticks’ dedication to high-quality, tailored solutions, the custom column integrates seamlessly into Biognosys’ workflows, addressing the company’s unwavering criteria for chromatography that maximises sensitivity, depth of coverage and reproducibility in the context of their broader platform. “Collaborating with the world-class team at Biognosys has been an incredibly rewarding experience. Developing a column that stands up to their rigorous performance and quality standards has been an exciting project, aligning well with our broader ambition to continue delivering the best performing columns to meet the expanding needs of the market,” says Xavier Perronnet, CEO of IonOpticks. “This partnership is consistent with our mission to work with the best, to develop columns that enable users to push the boundaries of proteomics research, whilst making LC-MS workflows for proteomics more accessible. Biognosys’ services are outstanding, and their offerings are extremely valuable to a diverse client base. We’re delighted to be contributing our expertise in chromatography to their overall offering,” Perronnet continues. “At Biognosys, our priority is to provide the best research services available to a broad array of biotech and pharma customers, requiring scrutiny of every aspect of our platforms to ensure they operate at their peak. Chromatographic performance, the separation of biological analytes prior to detection, is a critical factor for the success of LC-MS workflows and directly impacts discovery outcomes. We were keen to collaborate with the IonOpticks team to develop a chromatography column specifically tailored to our specific requirements, and they delivered,” says Lukas Reiter , Ph.D., Chief Technology Officer at Biognosys. IonOpticks and Biognosys are proud to collaborate and set new benchmarks in LC-MS-based research, reaffirming their commitment to delivering high-performance solutions that drive innovation and shape the future of proteomics. — ENDS — About IonOpticks IonOpticks produces high-performance chromatography solutions for the global research community enhancing mass spectrometry (LC-MS) and high-end proteomics research. Their solutions enhance the sensitivity of mass spectrometry sample analysis, enabling scientists and clinicians to discover more from their samples. These advancements are valuable for a broad range of applications within the field of biological and medical research including drug discovery, phosphoproteomics and shotgun proteomics. https://ionopticks.com/ About Biognosys At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. With our versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery ® , TrueTarget ® , and TrueSignature ® research service platforms, our flagship software Spectronaut ® , and the PQ500TM kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible. For more information, visit biognosys.com . View original content: https://www.prnewswire.com/apac/news-releases/ionopticks-custom-chromatography-column-to-become-biognosys-standard-for-high-quality-proteomic-insights-302323523.html SOURCE IonOpticksAn online debate over foreign workers in tech shows tensions in Trump’s political coalition
Fox News Flash top sports headlines are here. Check out what's clicking on Foxnews.com. Former ESPN insider Adrian Wojnarowski was the best in the business, and that’s supposedly why the Harris campaign picked the ESPN insider to break the news of Vice President Kamala Harris’ running mate. In an interview with Sports Illustrated, senior writer Chris Mannix reported the Harris campaign had reached out to the beloved NBA insider in August to break the news that Minnesota Gov. Tim Walz would be added to the Democratic ticket alongside Harris. Vice Presidential candidate Tim Walz speaks at Manitowoc Pattern and Machining Oct. 28, 2024, in Manitowoc, Wis. (Imagn) "Consider: In August, representatives from Kamala Harris’s presidential campaign reached out. They had settled on their nominee for vice president and wanted Woj to break it. Alas, another outlet scooped him before he could," Mannix wrote. CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COM It wasn’t clear which outlet first broke the news, but just a month later, Wojnarowski announced his exit from the network. Vice President Kamala Harris gestures as she delivers a concession speech for the 2024 presidential election Nov. 6, 2024, on the campus of Howard University in Washington. (AP Photo/Stephanie Scarbrough) EX-ESPN STAR ADRIAN WOJNAROWSKI REVEALS CANCER BATTLE Representatives from the Harris campaign did not immediately respond to Fox News Digital’s request for comment. Wojnarowski announced in Thursday’s interview that he was diagnosed with prostate cancer before he decided to leave ESPN to take a job at St. Bonaventure. "When you hear cancer, you think about it going through your body like Pac-Man," Wojnarowski said. "Prostate cancer, it generally stays confined to your prostate and is typically slow growing." Adrian Wojnarowski before a game March 16, 2024, at Crypto.Com Arena in Los Angeles. (Adam Pantozzi/NBAE via Getty Images) CLICK HERE TO GET THE FOX NEWS APP While his diagnosis did not force his retirement from ESPN, it did open his eyes. "It made me remember that the job isn’t everything. In the end, it’s just going to be your family and close friends. And it’s also, like, nobody gives a s---. Nobody remembers [breaking stories] in the end. It’s just vapor." Fox News’ Ryan Gaydos contributed to this report. Follow Fox News Digital’s sports coverage on X , and subscribe to the Fox News Sports Huddle newsletter . Paulina Dedaj is a Sports Reporter for Fox News Digital.Top 10 movies of 2024: In a time of scoundrels, ‘Brutalist,’ ‘Challengers’ and the movie about the exotic dancer
NEW YORK (AP) — Bitcoin topped $100,000 for the first time this week as a massive rally in the world's most popular cryptocurrency, largely accelerated by the election of Donald Trump, rolls on. The cryptocurrency officially to rose six figures Wednesday night, just hours after the president-elect said he intends to nominate cryptocurrency advocate Paul Atkins to be the next chair of the Securities and Exchange Commission. Bitcoin has soared since Trump won the U.S. presidential election on Nov. 5. The asset climbed from $69,374 on Election Day, hitting as high as $103,713 Wednesday, according to CoinDesk. And the latest all-time high arrives just two years after bitcoin dropped below $17,000 following the collapse of crypto exchange FTX . Bitcoin fell back below the $100,000 by Thursday afternoon, sitting above $99,000 by 4 p.m. ET. Even amid a massive rally that has more than doubled the value of bitcoin this year, some experts continue to warn of investment risks around the asset, which has quite a volatile history. Here’s what you need to know. Cryptocurrency has been around for a while now. But chances are you’ve heard about it more and more over the last few years. In basic terms, cryptocurrency is digital money. This kind of currency is designed to work through an online network without a central authority — meaning it’s typically not backed by any government or banking institution — and transactions get recorded with technology called a blockchain. Bitcoin is the largest and oldest cryptocurrency, although other assets like ethereum, XRP, tether and dogecoin have also gained popularity over the years. Some investors see cryptocurrency as a “digital alternative” to traditional money, but most daily financial transactions are still conducted using fiat currencies such as the dollar. Also, bitcoin can be very volatile, with its price reliant on larger market conditions. A lot of the recent action has to do with the outcome of the U.S. presidential election. Trump, who was once a crypto skeptic, has pledged to make the U.S. “the crypto capital of the planet” and create a “strategic reserve” of bitcoin. His campaign accepted donations in cryptocurrency and he courted fans at a bitcoin conference in July. He also launched World Liberty Financial, a new venture with family members to trade cryptocurrencies. On Thursday morning, hours after bitcoin surpassed the $100,000 mark, Trump congratulated “BITCOINERS” on his social media platform Truth Social. He also appeared to take credit for the recent rally, writing, “YOU’RE WELCOME!!!” Top crypto players welcomed Trump’s election victory last month, in hopes that he would be able to push through legislative and regulatory changes that they’ve long lobbied for — which, generally speaking, aim for an increased sense of legitimacy without too much red tape. And the industry has made sizeable investments along the way. Back in August, Public Citizen, a left-leaning consumer rights advocacy nonprofit, reported finding that crypto-sector corporations spent more than $119 million in 2024 to back pro-crypto candidates across federal elections. Trump made his latest pro-crypto move when he announced his plans Wednesday to nominate Atkins to chair the SEC. Atkins was an SEC commissioner during the presidency of George W. Bush. In the years since leaving the agency, Atkins has made the case against too much market regulation. He joined the Token Alliance, a cryptocurrency advocacy organization, in 2017. Under current chair Gary Gensler, who will step down when Trump takes office, the SEC has cracked down on the crypto industry — penalizing a number of companies for violating securities laws. Gensler has also faced ample criticism from industry players in the process. One crypto-friendly move the SEC did make under Gensler was the approval in January of spot bitcoin ETFs, or exchange trade funds, which allow investors to have a stake in bitcoin without directly buying it. The spot ETFs were the dominant driver of bitcoin's price before Trump's win — but, like much of the crypto’s recent momentum, saw record inflows postelection. Bitcoin surpassing the coveted $100,000 mark has left much of the crypto world buzzing. “What we’re seeing isn’t just a rally — it’s a fundamental transformation of bitcoin’s place in the financial system,” Nathan McCauley, CEO and co-founder of crypto custodian Anchorage Digital, said in a statement — while pointing to the growth of who's entering the market, particularly with rising institutional adoption. Still, others note that the new heights of bitcoin's price don't necessarily mean the asset is going mainstream. The $100,000 level is “merely a psychological factor and ultimately just a number,” Dan Coatsworth, investment analyst at British investment company AJ Bell, wrote in a Thursday commentary . That being said, bitcoin could keep climbing to more and more all-time highs, particularly if Trump makes good on his promises for more crypto-friendly regulation once in office. If Trump actually makes a bitcoin reserve, for example, supply changes could also propel the price forward. “It is hard to overstate the magnitude of the change in Washington’s attitude towards crypto post-election,” Matt Hougan, chief investment officer at Bitwise Asset Management, said via email Thursday, reiterating that prices could keep rising if trends persist. “There is a lot more demand than there is supply, and that’s usually a pretty good recipe for success.” Still, as with everything in the volatile cryptoverse, the future is never promised. Worldwide regulatory uncertainties and environmental concerns around bitcoin “mining" — the creation of new bitcoin, which consumes a lot of energy — are among factors that analysts like Coatsworth note could hamper future growth. And, as still a relatively young asset with a history of volatility, longer-term adoption has yet to be seen through. Today’s excitement around bitcoin may make many who aren’t already in the space want to get in on the action. For those in a position to invest, Hougan says it's not too late — noting that bitcoin is still early in its development and most institutional investors “still have zero exposure.” At the same time, Hougan and others maintain that it's important to tread cautiously and not bite off more than you can chew. Experts continue to stress caution around getting carried away with crypto “FOMO,” or the fear of missing out, especially for small-pocketed investors. “A lot of people have got rich from the cryptocurrency soaring in value this year, but this high-risk asset isn’t suitable for everyone,” Coatsworth noted Thursday. “It’s volatile, unpredictable and is driven by speculation, none of which makes for a sleep-at-night investment.” In short, history shows you can lose money in crypto as quickly as you’ve made it. Long-term price behavior relies on larger market conditions. Trading continues at all hours, every day. Coatsworth points to recent research from the Bank for International Settlements, a Switzerland-based global organization of central banks, which found that about three-quarters of retail buyers on crypto exchange apps likely lost money on their bitcoin investments between 2015 and 2022. At the start of the COVID-19 pandemic, bitcoin stood at just over $5,000. Its price climbed to nearly $69,000 by November 2021, during high demand for technology assets, but later crashed during an aggressive series of rate hikes by the Federal Reserve. And the late-2022 collapse of FTX significantly undermined confidence in crypto overall, with bitcoin falling below $17,000. Investors began returning in large numbers as inflation started to cool — and gains skyrocketed on the anticipation and then early success of spot ETFs, and again, now the post-election frenzy. But lighter regulation from the coming Trump administration could also mean less guardrails. This story has been corrected to refer to Anchorage Digital as a crypto custodian, not a crypto asset manager.